SCHEMBL30974564

SCHEMBL30974564

CCOC(=O)/C(=C/COC1CCCCO1)CC(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ALDH1A1 P00352 5/20 0.31
HPGD P15428 3/20 0.31
KDM4E B2RXH2 2/20 0.31
POLB P06746 2/20 0.30
TSHR P16473 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
HSD17B10 Q99714 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
TP53 P04637 2/20 0.30
CYP2C19 P33261 2/20 0.30
NPC1 O15118 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C9 P11712 1/20 0.30
RAB9A P51151 1/20 0.30
GAA P10253 1/20 0.30
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13524339 0.80 MEN1 (0.35) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL9053520 0.76 KMT2A (0.37) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL9320935 0.74 ALDH1A1 (0.38) ALDH1A1HSD17B10CYP2C19CYP2D6
SCHEMBL12306794 0.73 MEN1 (0.37) MEN1KMT2ANPC1RAB9A
SCHEMBL6655640 0.72 MEN1 (0.43) MEN1KMT2AALDH1A1HPGDTP53
SCHEMBL5926284 0.72 MAPT (0.38) MEN1KMT2AALDH1A1RAB9A
SCHEMBL5926286 0.72 MAPT (0.38) MEN1KMT2AALDH1A1RAB9A
SCHEMBL18117298 0.71 HPGD (0.34) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL12046271 0.71 HPGD (0.34) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL13715373 0.71 NPSR1 (0.37) MEN1KMT2AALDH1A1TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4626481-A1 NOVEL LINKER DRUGS COMPRISING PHOSPHOANTIGENS, NOVEL CONJUGATES AND THEIR USE IN THERAPY Byondis B.V. (NL) 2025-10-08 EP disclosed
WO-2024133374-A1 NOVEL LINKER DRUGS COMPRISING PHOSPHOANTIGENS, NOVEL CONJUGATES AND THEIR USE IN THERAPY BYONDIS B.V. (NL) 2024-06-27 WO disclosed